https://www.taxtmi.com/caselaws?id=42782 The Supreme Court dismissed the appeal, affirming that Neftin-50 and Neftin-200 are patent and proprietary medicines under Item 14E and are not exempt from excise duty under Notification No. 6/84. The court found no merit in the discrimination claim, stating that wrongful exemptions to others do not entitle the appellant to similar treatment. The judgment underscores the importance of accurate classification and adherence to legal principles in tax matters. en-us Fri, 14 Sep 1990 00:00:00 +0530 Thu, 30 Jun 2016 13:11:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=42782 The Supreme Court dismissed the appeal, affirming that Neftin-50 and Neftin-200 are patent and proprietary medicines under Item 14E and are not exempt from excise duty under Notification No. 6/84. The court found no merit in the discrimination claim, stating that wrongful exemptions to others do not entitle the appellant to similar treatment. The judgment underscores the importance of accurate classification and adherence to legal principles in tax matters. Case-Laws Central Excise Fri, 14 Sep 1990 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=42782